Ethical dilemma for Ebola drug trials

Nature. 2014 Nov 13;515(7526):177-8. doi: 10.1038/515177a.
No abstract available

Publication types

  • News

MeSH terms

  • Africa, Western / epidemiology
  • Antibodies, Viral / immunology
  • Antibodies, Viral / therapeutic use
  • Blood Grouping and Crossmatching
  • Compassionate Use Trials / ethics
  • Compassionate Use Trials / standards
  • Controlled Clinical Trials as Topic / ethics*
  • Controlled Clinical Trials as Topic / standards
  • Ebolavirus / immunology
  • Evidence-Based Medicine / ethics*
  • Evidence-Based Medicine / standards*
  • Hemorrhagic Fever, Ebola / drug therapy
  • Hemorrhagic Fever, Ebola / epidemiology
  • Hemorrhagic Fever, Ebola / immunology
  • Hemorrhagic Fever, Ebola / therapy*
  • Humans
  • Immune Sera / immunology
  • Immunization, Passive
  • National Institutes of Health (U.S.)
  • Public Health / ethics
  • Treatment Outcome
  • United States
  • World Health Organization

Substances

  • Antibodies, Viral
  • Immune Sera